by Tony Dammicci | Mar 15, 2023 | Press Releases
Paris and Red Bank, N.J. March 13, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under...
by Jim Foley | Nov 29, 2022 | Press Releases
DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...
by Jim Foley | Nov 17, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...
by Jim Foley | Nov 11, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / November 11, 2022 / MDB Capital Holdings, LLC (“MDB”), a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today...
by Tyler Teske | Oct 6, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / October 6, 2022 / MDB Capital Holdings, LLC, a privately held Public Venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced the...
by Jim Foley | Oct 3, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / October 3, 2022 / MDB Capital Holdings, LLC, a privately held Public Venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced the...
Recent Comments